• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Hungary Pharmaceuticals and Healthcare Report Q2 2010 - Product Image

Hungary Pharmaceuticals and Healthcare Report Q2 2010

  • Published: February 2010
  • Region: Hungary
  • 84 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Eli Lilly
  • Gedeon Richter
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • MORE

Business Monitor International's Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Hungary's pharmaceuticals and healthcare industry.

Regulatory pressures have placed considerable pressures on pharmaceutical companies operating in Hungary in recent years. The introduction of the Pharma-Economic Act in 2007 and subsequent revisions to pricing, reimbursement and prescribing directives have limited attractiveness from a domestic revenue perspective. In BMI’s Business Environment Ratings for Q210 Hungary is eighth of the 20 markets analysed in Emerging Europe, highlighting that despite tough regulations, positive factors remain for drugmakers.

Hungary’s pharmaceutical market is the fourth-largest in the region, with above-average spending on a per-capita basis and as a proportion of GDP. Despite a major market contraction in 2007, growth has returned. Budgetary restrictions within the National Health Insurance Fund (OEP) are likely to increase, particularly over the READ MORE >

Executive Summary

Hungary Pharmaceuticals And Healthcare Industry SWOT
- Hungary Political SWOT
- Hungary Economic SWOT
- Hungary Business Environment SWOT

Pharmaceuticals & Healthcare Business Environment
- Table: Emerging Europe Pharmaceutical Business Environment Ratings for Q210
- Limits to Potential Returns
- Risks to Realisation of Returns

Hungary – Market Summary
- Intellectual Property Regime
- Pricing Regime
- Table: Hungary – Pharmaceutical Price Build-Up
- Table: Hungary – Average Pharmacy Mark-Up
- Price Cuts
- Reimbursement Regime
- Industry Developments
- Epidemiology
- Healthcare Financing
- Health Insurance
- Healthcare Reforms
- Hospital Sector Reforms
- Research and Development (R&D)
- Table: Special Incentive Package For Investors Willing To Establish An R&D Facility Worth At Least EUR10mn in Hungary
- Recent R&D Sector Developments
- Industry Forecast Scenario
- Overall Market Forecast
- Key Growth Factors – Industry
- Key Growth Factors – Macroeconomic
- Table: Hungary – Economic Activity, 2007-2014
- Prescription Drug Market Forecast
- Patented Product Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Medical Device Market Forecast
- Key Risks to BMI’s Forecast Scenario

Competitive Landscape
- Pharmaceutical Industry
- Table: Leading Pharmaceutical Companies By Ownership
- Recent Company Activities
- Biotechnology Sector
- Wholesale and Retail Pharmacy Sector

Company Monitor
- Domestic Manufacturers
- Gedeon Richter
- Egis Pharmaceuticals (Servier)
- Multinational Companies
- Pfizer
- Novartis
- Sanofi-Aventis
- GlaxoSmithKline
- Merck & Co
- Eli Lilly
- Teva

Country Snapshot: Hungary Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education and Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market and Spending Power
- Table: Employment Indicators, 2001-2006
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Wages, 2000-2012

BMI Methodology
- How BMI Generate Their Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
- Forecast Tables

- Gedeon Richter
- Egis Pharmaceuticals (Servier)
- Pfizer
- Novartis
- Sanofi-Aventis
- GlaxoSmithKline
- Merck & Co
- Eli Lilly
- Teva

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos